Literature DB >> 7144744

Physical and catalytic properties of the isozymes of adenosine deaminase from human red blood cells.

R MacQuarrie, E Buel.   

Abstract

Adenosine deaminase (adenosine aminohydrolase, EC3.5.4.4) has been purified from human erythrocytes using a simple chromatographic procedure. Purified enzyme was obtained from individuals who were homozygous for the principal isozyme (ADA 1) as well as from individuals who were heterogyzous for the major variant (ADA 2-1). Although ADA 1 and ADA 2-1 are electrophoretically distinguishable, they have many common physical and catalytic properties. No significant differences between the two isozymic forms were found in measurements of molecular weight, catalytic activity in the presence of various substrates and inhibitors, pH optimum, turnover number, and stability in conditions of both high and low pH. ADA 2-1 was, however, substantially less stable than ADA 1 with respect to thermal denaturation. These studies support the idea that adenosine deaminase activity in erythrocytes is lower in those individuals who possess the variant form of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7144744     DOI: 10.1007/bf00227611

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

1.  Adenosine deaminase from human erythrocytes: purification and effects of adenosine analogs.

Authors:  R P Agarwal; S M Sagar; R E Parks
Journal:  Biochem Pharmacol       Date:  1975-03-15       Impact factor: 5.858

2.  Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin.

Authors:  S Cha; R P Agarwal; R E Parks
Journal:  Biochem Pharmacol       Date:  1975-12-01       Impact factor: 5.858

3.  Rapid and efficient separation and identification of the two molecular forms of human adenosine deaminase by thin-layer gel filtration chromatography.

Authors:  P F Ma; S Betras; G Dunnington
Journal:  Anal Biochem       Date:  1976-09       Impact factor: 3.365

4.  Purification and subunit structure of adenosine deaminase from human kidney.

Authors:  W P Schrader; A R Stacy
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

5.  Comparative activity of red cell adenosine deaminase allelic forms.

Authors:  G Battistuzzi; R Scozzari; P Santolamazza; L Terrenato; G Modiano
Journal:  Nature       Date:  1974-10-25       Impact factor: 49.962

6.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

7.  Partial purification and properties of the common inherited forms of adenosine deaminase from human erythrocytes.

Authors:  W R Osborne; N Spencer
Journal:  Biochem J       Date:  1973-05       Impact factor: 3.857

8.  Adenosine deaminase isozymes in human tissues.

Authors:  Y H Edwards; D A Hopkinson; H Harris
Journal:  Ann Hum Genet       Date:  1971-10       Impact factor: 1.670

9.  Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors.

Authors:  R P Agarwal; T Spector; R E Parks
Journal:  Biochem Pharmacol       Date:  1977-03-01       Impact factor: 5.858

10.  Adenosine deaminase from human erythrocytes.

Authors:  R P Agarwal; R E Parks
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

View more
  1 in total

1.  Partial purification and properties of long-chain acyl-CoA hydrolase from rat brain cytosol.

Authors:  A Y Lin; G Y Sun; R MacQuarrie
Journal:  Neurochem Res       Date:  1984-11       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.